Previous reports [54–56] have shown that the BMPR2 (bone morphogenetic protein receptor 2, a member of the TGFβR superfamily) level decreased, while its antagonist, GREM1, expression level increased, and that TGFβR was downregulated in IPF. This evidence concerns the gene GREM1 and idiopathic pulmonary fibrosis.